Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
$25.63
+0.4%
$25.63
$22.22
$26.13
$8.20M-1.061,379 shs9,200 shs
Fission Uranium Corp. stock logo
FCU
Fission Uranium
C$1.04
-3.7%
C$1.04
C$0.54
C$1.33
C$867.82M2.862.41 million shs1.02 million shs
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
C$3.07
C$1.66
C$4.85
C$553.23MN/A669,999 shs1.96 million shs
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
C$2.72
+1.9%
C$3.17
C$2.55
C$5.66
C$250.54M1.966,948 shs16,553 shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$126.19
-1.9%
$126.66
$75.56
$138.28
$566.28B0.414.83 million shs2.77 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
0.00%0.00%0.00%0.00%0.00%
Fission Uranium Corp. stock logo
FCU
Fission Uranium
+2.86%0.00%+6.93%-12.90%+92.86%
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
0.00%0.00%0.00%0.00%0.00%
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
-2.55%-7.29%-11.00%-9.80%-51.89%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+2.71%+4.19%-0.11%+22.25%+201.78%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
1.6763 of 5 stars
3.50.00.00.03.11.70.0
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/AN/AN/A
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
N/AN/AN/AN/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
3.0743 of 5 stars
1.45.02.50.03.20.03.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
0.00
N/AN/AN/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
3.00
BuyC$1.7568.27% Upside
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/A
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
3.00
BuyC$8.50212.50% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.75
Moderate Buy$133.605.87% Upside

Current Analyst Ratings

Latest KDX, FCU, NVO, CSH, and NOU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
4/12/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$163.00
4/1/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
3/20/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
2/20/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$140.00
2/14/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$140.00
2/1/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$120.00 ➝ $140.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/AN/AN/AN/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
N/AN/AC$0.06 per share17.71C$0.58 per shareN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/A
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
N/AN/AC$0.11 per share24.42C$1.12 per shareN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$33.71B16.80$3.03 per share41.60$3.45 per share36.58

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/A28.81N/AN/AN/AN/AN/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
-C$8.92M-C$0.01N/AN/AN/A-2.10%-1.80%5/20/2024 (Estimated)
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
-C$44.24M-C$0.79N/AN/AN/A-61.91%-28.25%5/8/2024 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$12.15B$2.7146.6530.852.0936.03%90.36%29.18%5/2/2024 (Confirmed)

Latest KDX, FCU, NVO, CSH, and NOU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.77N/A-$0.77N/AN/AN/A  
3/27/2024Q4 2023
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
-C$0.23-C$0.27-C$0.04-C$0.27N/AN/A
1/31/2024Q4 2023
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.66$0.71+$0.05$0.71$9.14 billion$9.51 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/AN/AN/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
N/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/A
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.331.05%+16.52%49.17%1 Years

Latest KDX, FCU, NVO, CSH, and NOU Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/31/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Semi-Annual$0.66400.9%3/22/20243/25/20244/2/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
0.08
28.29
20.34
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/A
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
84.23
5.48
1.29
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.19
0.82
0.64

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/A320,000N/ANot Optionable
Fission Uranium Corp. stock logo
FCU
Fission Uranium
17834.44 millionN/ANot Optionable
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A180.21 millionN/ANot Optionable
Nouveau Monde Graphite Inc. stock logo
NOU
Nouveau Monde Graphite
12292.11 millionN/ANot Optionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
63,3704.49 billion4.48 billionOptionable

KDX, FCU, NVO, CSH, and NOU Headlines

SourceHeadline
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
cnbc.com - April 24 at 3:22 PM
US Senate committee investigates pricing of Novos Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and Wegovy
reuters.com - April 24 at 2:37 PM
3 Biotech Stocks With Skyrocketing Potential: April 20243 Biotech Stocks With Skyrocketing Potential: April 2024
investorplace.com - April 24 at 11:36 AM
4 Large Drug Stocks to Hold on to Amid Industry Challenges4 Large Drug Stocks to Hold on to Amid Industry Challenges
zacks.com - April 24 at 11:11 AM
Novo Nordisk A/S - Articles of Association, April 2024Novo Nordisk A/S - Articles of Association, April 2024
globenewswire.com - April 24 at 8:57 AM
Novo Nordisk A/S – Reduction of the share capitalNovo Nordisk A/S – Reduction of the share capital
globenewswire.com - April 24 at 8:48 AM
abrdn plc Takes $23.55 Million Position in Novo Nordisk A/S (NYSE:NVO)abrdn plc Takes $23.55 Million Position in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 24 at 6:14 AM
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
fool.com - April 24 at 5:50 AM
Schnieders Capital Management LLC Boosts Position in Novo Nordisk A/S (NYSE:NVO)Schnieders Capital Management LLC Boosts Position in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 23 at 11:25 PM
Novo Nordisk A/S (NYSE:NVO) Stock Price Up 2.1%Novo Nordisk A/S (NYSE:NVO) Stock Price Up 2.1%
marketbeat.com - April 23 at 2:58 PM
Novo Nordisk (NVO) Boasts Earnings & Price Momentum: Should You Buy?Novo Nordisk (NVO) Boasts Earnings & Price Momentum: Should You Buy?
zacks.com - April 23 at 10:31 AM
Why Novo Nordisk Topped the Market TodayWhy Novo Nordisk Topped the Market Today
fool.com - April 22 at 6:08 PM
RWA Wealth Partners LLC Acquires 72,924 Shares of Novo Nordisk A/S (NYSE:NVO)RWA Wealth Partners LLC Acquires 72,924 Shares of Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 22 at 3:46 PM
Novo Nordisk A/S (NYSE:NVO) Stock Price Up 1.7%Novo Nordisk A/S (NYSE:NVO) Stock Price Up 1.7%
marketbeat.com - April 22 at 2:32 PM
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lillys Weight Loss Drugs Reshaping Food SpendingChanging Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
msn.com - April 22 at 2:31 PM
Novo Nordisk A/S - share repurchase programmeNovo Nordisk A/S - share repurchase programme
globenewswire.com - April 22 at 9:06 AM
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
marketbeat.com - April 22 at 6:05 AM
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
marketbeat.com - April 22 at 6:05 AM
Shikiar Asset Management Inc. Has $13.14 Million Stock Position in Novo Nordisk A/S (NYSE:NVO)Shikiar Asset Management Inc. Has $13.14 Million Stock Position in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 21 at 4:51 PM
Novo Nordisk A/S (NYSE:NVO) Trading Up 0.5%Novo Nordisk A/S (NYSE:NVO) Trading Up 0.5%
americanbankingnews.com - April 21 at 3:56 AM
Riggs Asset Managment Co. Inc. Takes $4.79 Million Position in Novo Nordisk A/S (NYSE:NVO)Riggs Asset Managment Co. Inc. Takes $4.79 Million Position in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 20 at 5:36 PM
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
fool.com - April 20 at 9:45 AM
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant PotentialMissed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
fool.com - April 20 at 8:30 AM
MarketBeat Week in Review – 4/15 - 4/19 (NVO)MarketBeat Week in Review – 4/15 - 4/19 (NVO)
marketbeat.com - April 20 at 7:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Morgan Creek-Exos Active SPAC Arbitrage ETF logo

Morgan Creek-Exos Active SPAC Arbitrage ETF

NYSEARCA:CSH
The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) is an exchange-traded fund that mostly invests in extended market equity. The fund is actively managed to provide exposure to US-listed pre-combination special purpose acquisition companies (SPACs) through the use of common stock, warrants and rights. Positions will generally be in small- and mid-cap companies. CSH was launched on Feb 1, 2022 and is managed by Morgan Creek.
Fission Uranium logo

Fission Uranium

TSE:FCU
Fission Uranium Corp. engages in the acquisition, exploration, and development of uranium resource properties in Canada. Its flagship property is the 100% owned Patterson Lake South property with 17 contiguous mineral claims covering an area of 31,039 ha located in the Athabasca Basin region of Saskatchewan, Canada. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.
Klondex Mines logo

Klondex Mines

TSE:KDX
Klondex Mines Ltd., together with its subsidiaries, acquires, explores, develops, and produces mineral properties in the United States and Canada. It primarily explores for gold and silver deposits. The company holds 100% interests in the Fire Creek mine covering approximately 19,000 acres located in Lander County; the Midas mine and ore milling facility covering approximately 30,000 acres situated in Elko County; and the Hollister mine approximately 18,000 acres located in Elko County. It also has 100% interests in the True North gold mine and mill covering approximately 39,868 hectares situated in Manitoba, Canada; and the Aurora mine and ore milling facility covering approximately 5,004 contiguous acres located in Nevada, as well as in the Ogama-Rockland property in Manitoba, Canada. The company was formerly known as Attila Resources Limited and changed its name to Klondex Mines Ltd. in October 1974. Klondex Mines Ltd. was founded in 1971 and is headquartered in Reno, Nevada.
Nouveau Monde Graphite logo

Nouveau Monde Graphite

CVE:NOU
Nouveau Monde Graphite Inc. engages in the acquisition, exploration, development, and evaluation of mineral properties in Canada. It primarily explores for graphite. The company's holds interest in the Matawinie Mine Project and the Battery Material Plant project situated in the Montreal, Quebec. It also engages in the real estate and trading businesses. The company was formerly known as Nouveau Monde Mining Enterprises Inc. and changed its name to Nouveau Monde Graphite Inc. in February 2017. Nouveau Monde Graphite Inc. was founded in 2011 and is headquartered in Saint-Michel-des-Saints, Canada.
Novo Nordisk A/S logo

Novo Nordisk A/S

NYSE:NVO
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.